Three new Trustees bring more skills and experience to LifeArc

A very warm welcome to three new Trustees who have joined our Board.

LifeArc invests in Cumulus Neuroscience

Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund

LifeArc co-leads £6 million funding in DJS Antibodies

LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…

LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics

Funding to help drive the development of new cancer therapies

LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases

Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories

LifeArc invests £1.5 million in Ducentis BioTherapeutics

LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease